ecallantide: Clinical Trials

3 completed. 3 Phase 3.

By phase and status

Phase	Trials	Status
Phase 3	3	Completed 3

Follow ecallantide: new trials by email Literature Review of ecallantide trials Research Report on ecallantide

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
Efficacy Study of DX-88 (Ecallantide) to Treat Acute Attacks of Hereditary Angioedema (HAE) ecallantide, Phosphate Buffer Saline (PBS), pH 7.0 - Hereditary Angioedema (HAE)	Phase 3	Completed	Shire	96	2007-04-01	2021-06-08
Safety and Efficacy Study of Repeated Doses of DX-88 (Ecallantide) to Treat Attacks of Hereditary Angioedema (HAE) ecallantide - Hereditary Angioedema (HAE)	Phase 3	Completed	Shire	147	2007-04-01	2021-06-08
Efficacy and Safety Study of DX-88 to Treat Acute Attacks of Hereditary Angioedema (HAE) ecallantide, Phosphate Buffer Saline (PBS), - Hereditary Angioedema (HAE)	Phase 3	Completed	Shire	91	2005-12-31	2021-06-11

Conditions studied

Angioedemas, Hereditary (3)

Sponsors

Shire (3)

Countries

United States (3)  ·  Canada (2)  ·  Jordan (2)

Results publications

PMID 23548529, PMID 23878046, PMID 24712435, PMID 21130380, PMID 22765833, PMID 23548526, PMID 20818887